ArticleVaccine2021

Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults.

Limor Friedensohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.